Vincenzo Cerullo

Helsinki, 00014, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 116 publications

Corrigendum to 'Design and in vitro validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanoma' [Mater. Today Bio 36, February 2026, 102693, https://doi.org/10.1016/j.mtbio.2025.102693].

Corrigendum to 'Design and in vitro validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanoma' [Mater. Today Bio 36, February 2026, 102693, https://doi.org/10.1016/j.mtbio.2025.102693].

Journal: Materials today. Bio

Published: April 02, 2026

Precision tumor-on-chip for personalized assessment of drug efficacy and immune cell delivery.

Precision tumor-on-chip for personalized assessment of drug efficacy and immune cell delivery.

Journal: Cell reports methods

Published: December 19, 2025

Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy.

Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy.

Journal: Frontiers in immunology

Published: December 04, 2025

Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.

Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.

Journal: Molecular therapy. Oncology

Published: October 29, 2025

Design and in vitro validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanoma.

Design and in vitro validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanoma.

Journal: Materials today. Bio

Published: October 23, 2025

Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.

Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: October 10, 2025

Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity.

Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity.

Journal: Nature communications

Published: August 27, 2025

Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomes.

Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomes.

Journal: Cancer discovery

Published: August 27, 2025

Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.

Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.

Journal: Cancer discovery

Published: August 27, 2025

Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4.

Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4.

Journal: iScience

Published: June 23, 2025

High-capacity adenoviral vector-mediated expression of an LDLR/transferrin chimeric protein in muscle reduces atherosclerosis in Ldlr-/- mice.

High-capacity adenoviral vector-mediated expression of an LDLR/transferrin chimeric protein in muscle reduces atherosclerosis in Ldlr-/- mice.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 29, 2025

Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.

Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.

Journal: Nature communications

Published: April 16, 2025

Showing 1-12 of 116

Last Updated: 09/26/2026